VIGIL HEMOGLOBIN (HBALC) CONTROLS
K-Number: K982022 · 1998-07-06
Advertisement
Device Summary
Frequently Asked Questions
What is the VIGIL HEMOGLOBIN (HBALC) CONTROLS?
VIGIL HEMOGLOBIN (HBALC) CONTROLS is a medical device that received FDA 510(k) clearance on 1998-07-06. The listed applicant is Beckman Coulter, Inc.. The 510(k) number is K982022.
When did VIGIL HEMOGLOBIN (HBALC) CONTROLS receive FDA 510(k) clearance?
VIGIL HEMOGLOBIN (HBALC) CONTROLS received FDA 510(k) clearance on 1998-07-06, under 510(k) number K982022.
Who is the listed applicant for VIGIL HEMOGLOBIN (HBALC) CONTROLS?
The FDA 510(k) record lists Beckman Coulter, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for VIGIL HEMOGLOBIN (HBALC) CONTROLS?
The FDA product code for VIGIL HEMOGLOBIN (HBALC) CONTROLS is JJX.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Beckman Coulter, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: JJX)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement